XBiotech Inc. — Director's Dealing 2020

Sep 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2020-09-10

Reporting Person: SHIVASWAMY SUSHMA (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-10	Common Shares	M	19332	$7.50	Acquired	19332	Direct
2020-09-10	Common Shares	S	19332	$20.01	Disposed	0	Direct
2020-09-15	Common Shares	M	20668	$7.50	Acquired	20668	Direct
2020-09-15	Common Shares	S	20668	$20.00	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-10	Stock options	$7.50	M	19332	Disposed	2021-02-28	Common Stocks (19332)	Direct
2020-09-15	Stock Options	$7.50	M	20668	Disposed	2021-02-28	Common Stocks (20668)	Direct